From the “Reasons Not To Put Government Bureaucrats In Charge Of Health Care” file comes this from — of all places — the New York Times.
A shift last year by the federal government in how it pays for drugs to treat dialysis patients may have had an unintended and potentially dire consequence, according to new research: a significant jump in blood transfusions for patients who now may not be getting enough of the medications.